LobbyingBoesen & Snow lobbying by quarter
Boesen & Snow's latest lobbying report covers Q2 2026, at $10K. The four quarters Q3 2025–Q2 2026 total $40K. Its first report covers Q2 2023; the issues it reports most are Pharmacy.
Boesen & Snow
- Latest quarter
- $10K
- Q2 2026 · 1 reports
- Last 12 months
- $40K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $10K | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $10K | 1 |
| Q1 2026 | $10K | 1 |
| Q2 2026 | $10K | 1 |
Policy issues the reports name
- Pharmacy13 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES13 reports
- SENATE13 reports
Firms it paid
| Firm | ||
|---|---|---|
| Da Vinci Group | $130K | 13 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Da Vinci Group | $10K |
| 04/17for Q1 | Da Vinci Group | $10K |
| 01/16for Q4 2025 | Da Vinci Group | $10K |
| 25/10/14for Q3 2025 | Da Vinci Group | $10K |
| 25/07/01for Q2 2025 | Da Vinci Group | $10K |
| 25/04/17for Q1 2025 | Da Vinci Group | $10K |
| 25/01/15for Q4 2024 | Da Vinci Group | $10K |
| 24/10/17for Q3 2024 | Da Vinci Group | $10K |
| 24/07/18for Q2 2024 | Da Vinci Group | $10K |
| 24/04/17for Q1 2024 | Da Vinci Group | $10K |
| 24/01/18for Q4 2023 | Da Vinci Group | $10K |
| 23/10/19for Q3 2023 | Da Vinci Group | $10K |
| 23/07/18for Q2 2023 | Da Vinci Group | $10K |
| 23/07/11for Q2 2023 | Da Vinci Group | Under $5,000 |